Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.5662/wjm.v7.i1.9 http://scihub22266oqcxt.onion/10.5662/wjm.v7.i1.9 C5366937!5366937!28396845     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=28396845&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 227.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       World+J+Methodol 2017 ; 7 (1): 9-15 Nephropedia Template TP {{tp|p=28396845|t=2017. Chromogranin A as a valid marker in oncology: Clinical application or false hopes?|pdf=|usr=}}{{28396845}} gab.com Text Chromogranin A as a valid marker in oncology: Clinical application or false hopes JO: World J Methodol http://www.kidney.de/pget.php?&tw=1&pmid=28396845 #FOAvip Chromogranin A, due to its primary expression throughout the neuroendocrine system, is a widely accepted biomarker for the assessment of neuro-endocrine tumors. It has been traditionally used in the management of patients with tumors of gastro-enteropancreatic origin. Lately, it has also been implicated in various conditions and diseases, both benign and malignant. However, the paucity of data of adequate strength, as well as its relation with common physiologic conditions and its interaction with commonly prescribed medications, limit its clinical use in only a narrow spectrum. Herein, we present a thorough review to the most frequent conditions where its levels are affected, focusing specifically on its potential use as a prognostic and predictive biomarker in oncology. Twit Text FOAVip Chromogranin A as a valid marker in oncology: Clinical application or false hopes ????World J Methodol http://www.kidney.de/pget.php?&tw=1&pmid=28396845 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28396845 #FOAvip English Wikipedia <ref>{{Cite pmid|28396845}}</ref> Chromogranin A as a valid marker in oncology: Clinical application or false hopes? #MMPMID28396845 Gkolfinopoulos S; Tsapakidis K; Papadimitriou K; Papamichael D; Kountourakis P World J Methodol 2017[Mar]; 7 (1): 9-15 PMID28396845show ga Chromogranin A, due to its primary expression throughout the neuroendocrine system, is a widely accepted biomarker for the assessment of neuro-endocrine tumors. It has been traditionally used in the management of patients with tumors of gastro-enteropancreatic origin. Lately, it has also been implicated in various conditions and diseases, both benign and malignant. However, the paucity of data of adequate strength, as well as its relation with common physiologic conditions and its interaction with commonly prescribed medications, limit its clinical use in only a narrow spectrum. Herein, we present a thorough review to the most frequent conditions where its levels are affected, focusing specifically on its potential use as a prognostic and predictive biomarker in oncology. äChromogranin A as a valid marker in oncology: Clinical application or (epmc).pdf DeepDyve Pubget Overpricing